Skip to main content
SCTX filings

Corporate insider profile

Behzad Aghazadeh Filing Activity

Latest reported as Corporate insider of Scribe Therapeutics, Inc. (SCTX).

Purchase filings
1
Reported companies
1
Net open-market value
$36,259,777
Latest transaction
Jul 28, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jul 28, 2026Scribe Therapeutics, Inc. (SCTX)Corporate insiderOpen Market Purchase2,391,238$15.16$36,259,777